Canadian Study of Adherence Outcomes in Adalimumab Patients: Three-Year Results from the COMPANION Study in Rheumatology Patients

被引：0
|
作者：
Bessette, Louis [1 ]
Lebovic, Gerald [2 ,3 ]
Millson, Brad [4 ]
Sung, Michael [4 ]
Gaetano, Tania [5 ]
Latour, Martin [5 ]
Laliberte, Marie-Claude [5 ]
机构：
[1] Ctr Hosp Univ Laval, Quebec City, PQ, Canada
[2] St Michaels Hosp, Appl Hlth Res Ctr, Toronto, ON, Canada
[3] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada
[4] QuintilesIMS, Kirkland, WA USA
[5] AbbVie, St Laurent, PQ, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2017年 / 44卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
16
引用
收藏
页码：866 / 866
页数：1
相关论文
共 50 条
  • [21] Three-Year Outcomes of Individualized Ranibizumab Treatment in Patients with Diabetic Macular Edema: The RESTORE Extension Study
    Schmidt-Erfurth, Ursula
    Lang, Gabriele E.
    Holz, Frank G.
    Schlingemann, Reinier O.
    Lanzetta, Paolo
    Massin, Pascale
    Gerstner, Ortrud
    Bouazza, Abdelkader Si
    Shen, Haige
    Osborne, Aaron
    Mitchell, Paul
    OPHTHALMOLOGY, 2014, 121 (05) : 1045 - 1053
  • [22] Three-Year Outcomes Following Permissive Cardiotoxicity in Patients on Trastuzumab
    Zhou, Shijie
    Cirne, Filipe
    Chow, Justin
    Zereshkian, Arman
    Bordeleau, Louise
    Dhesy-Thind, Sukhbinder
    Ellis, Peter M.
    Mukherjee, Som D.
    Aghel, Nazanin
    Leong, Darryl P.
    ONCOLOGIST, 2023, 28 (09): : E712 - E722
  • [23] Rheumatology patients' use of complementary therapies: Results from a one-year longitudinal study
    Rao, JK
    Kroenke, K
    Mihaliak, KA
    Grambow, SC
    Weinberger, M
    ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2003, 49 (05): : 619 - 625
  • [24] Remission and relapse in the outpatient care of schizophrenia -: Three-year results from the Schizophrenia Outpatient Health Outcomes Study
    Maria Haro, Josep
    Novick, Diego
    Suarez, David
    Alonso, Jordi
    Pierre Lepine, Jean
    Ratcliffe, Mark
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2006, 26 (06) : 571 - 578
  • [25] Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study
    Bessette, Louis
    Lebovic, Gerald
    Millson, Brad
    Charland, Katia
    Donepudi, Krishna
    Gaetano, Tania
    Remple, Valencia
    Latour, Martin G.
    Gazel, Sandra
    Laliberte, Marie-Claude
    Thorne, Carter
    RHEUMATOLOGY AND THERAPY, 2018, 5 (01) : 75 - 85
  • [26] IMPACT OF THE ADALIMUMAB PATIENT SUPPORT PROGRAM ON CLINICAL OUTCOMES IN ANKYLOSING SPONDYLITIS: RESULTS FROM THE COMPANION STUDY
    Bessette, L.
    Thorne, C.
    Millson, B.
    Charland, K.
    Donepudi, K.
    Gaetano, T.
    Remple, V.
    Latour, M.
    Laliberte, M-C.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 349 - 349
  • [27] Impact of the Adalimumab Patient Support Program on Clinical Outcomes in Ankylosing Spondylitis: Results from the COMPANION Study
    Louis Bessette
    Gerald Lebovic
    Brad Millson
    Katia Charland
    Krishna Donepudi
    Tania Gaetano
    Valencia Remple
    Martin G. Latour
    Sandra Gazel
    Marie-Claude Laliberté
    Carter Thorne
    Rheumatology and Therapy, 2018, 5 : 75 - 85
  • [28] Three-Year Outcomes of Transcatheter Aortic Valve Implantation in Patients With Varying Levels of Surgical Risk (from the CoreValve ADVANCE Study)
    Barbanti, Marco
    Schiltgen, Molly
    Verdoliva, Sarah
    Bosmans, Johan
    Bleiziffer, Sabine
    Gerckens, Ulrich
    Wenaweser, Peter
    Brecker, Stephen
    Gulino, Simona
    Tamburino, Corrado
    Linke, Axel
    AMERICAN JOURNAL OF CARDIOLOGY, 2016, 117 (05): : 820 - 827
  • [29] Three-year Outcomes in De Novo Liver Transplant Patients Receiving Everolimus With Reduced Tacrolimus: Follow-Up Results From a Randomized, Multicenter Study
    Fischer, Lutz
    Saliba, Faouzi
    Kaiser, Gernot M.
    De Carlis, Luciano
    Metselaar, Herold J.
    De Simone, Paolo
    Duvoux, Christophe
    Nevens, Frederik
    Fung, John J.
    Dong, Gaohong
    Rauer, Barbara
    Junge, Guido
    TRANSPLANTATION, 2015, 99 (07) : 1455 - 1462
  • [30] Three-year efficacy and safety results from a study of everolimus versus mycophenolate mofetil in de novo renal transplant patients
    Vítko, S
    Margreiter, R
    Weimar, W
    Dantal, J
    Kuypers, D
    Winkler, M
    Oyen, O
    Viljoen, HG
    Filiptsev, P
    Sadek, S
    Li, YL
    Cretin, N
    Budde, K
    AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (10) : 2521 - 2530
12345